Bionano Genomics Inc. (BNGO)

Overview

Bionano Genomics, Inc. specializes in comprehensive genome analysis software designed to assist genomics labs in the interpretation and analysis of data across various platforms, offering insightful data visualizations for easy reporting of causative variants. The company aims to advance genome analysis and understanding of genetic variations and their functions. Established in 2003 and based in San Diego, California, Bionano Genomics provides a suite of products and services that cater to the needs of the genetic research community, offering innovative solutions for structural variation analysis and genetic testing services.

Products and Services

• Saphyr - A comprehensive sample-to-result solution designed for structural variation analysis through optical genome mapping. It serves as a pivotal tool for genome analysis, allowing for a deeper understanding of genetic variation and function.
• Saphyr Instrument - A sophisticated single-molecule imager essential for the operation of the Saphyr system. It is designed to accurately capture and analyze genomic information.
• Saphyr Chip - A critical consumable that facilitates the packaging of nanochannel arrays for DNA linearization, enabling precise and efficient genome mapping processes.
• Bionano Prep Kits and DNA Labeling Kits - These kits provide the necessary reagents and protocols for extracting and labeling ultra-high molecular weight DNA, essential for the analysis performed by Saphyr.
• Saphyr and Bionano Compute Servers - Powerful computing solutions offered by the company to support the data analysis demands of the Saphyr system, ensuring efficient processing and interpretation of genomic data.
• VIA Software - An integrated system for the analysis and interpretation of genomic variants from various data sources, including microarray and next-generation sequencing. Designed for use in cytogenetics and molecular genetics, VIA software enhances the understanding of genomic data.

Additionally, Bionano Genomics provides an array of testing and laboratory services to support the diagnosis and research of genetic conditions:

• FirstStepDx PLUS - A chromosomal microarray test aimed at identifying the genetic underpinnings in individuals with autism spectrum disorder, developmental delays, and intellectual disability.
• Fragile X Syndrome (FXS) Testing Services - Specialized testing services for detecting Fragile X syndrome, a genetic condition associated with intellectual disability.
• NextStepDx PLUS - An exome sequencing test designed to identify genetic variants related to childhood development disorders, enhancing the diagnostic process.
• OGM-Dx HemeOne Testing - A service offering genetic testing for hematological conditions, utilizing optical genome mapping to provide comprehensive results.
• OGM-Dx FSHD - A genetic test catered for individuals suspected of having FSHD type 1, facilitating the diagnosis of this muscular disorder.
• OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV - Comprehensive testing services for structural variations in the genome, available for both postnatal and prenatal assessments to provide extensive insights into genetic health.